Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems - PubMed (original) (raw)

Review

. 2017 Mar;24(3):133-143.

doi: 10.1038/gt.2017.5. Epub 2017 Jan 17.

Affiliations

Review

Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems

S Guan et al. Gene Ther. 2017 Mar.

Abstract

Because of its safe and effective protein expression profile, in vitro transcribed messenger RNA (IVT-mRNA) represents a promising candidate in the development of novel therapeutics for genetic diseases, vaccines or gene editing strategies, especially when its inherent shortcomings (for example, instability and immunogenicity) have been partially addressed via structural modifications. However, numerous unsolved technical difficulties in successful in vivo delivery of IVT-mRNA have greatly hindered the applications of IVT-mRNA in clinical development. Recent advances in nanotechnology and material science have yielded many promising nonviral delivery systems, some of which were able to efficiently facilitate targeted in vivo delivery of IVT-mRNA in safe and noninvasive manners. The diversity and flexibility of these delivery systems highlight the recent progress of IVT-mRNA-based therapy using nonviral vectors. In this review, we summarize recent advances of existing and emerging nonviral vector-based nanotechnologies for IVT-mRNA delivery and briefly summarize the interesting but rarely discussed applications on simultaneous delivery of IVT-mRNA with DNA.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Control Release. 2015 Mar 10;201:41-8 - PubMed
    1. Cancer Gene Ther. 2007 Sep;14(9):802-14 - PubMed
    1. AAPS PharmSciTech. 2008;9(1):288-94 - PubMed
    1. Chem Commun (Camb). 2010 Jun 21;46(23):4151-3 - PubMed
    1. BMC Genomics. 2009 Oct 16;10:477 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources